Intuitive Surgical, Inc. (NASDAQ:ISRG) Insider Jamie Samath Sells 269 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) insider Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Jamie Samath also recently made the following trade(s):

• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00.

Intuitive Surgical Trading Down 0.1 %

Intuitive Surgical stock opened at $536.69 on Thursday. The stock has a 50-day moving average price of $495.85 and a 200 day moving average price of $455.08. Intuitive Surgical, Inc. has a 52 week low of $287.98 and a 52 week high of $542.59. The stock has a market cap of $191.16 billion, a PE ratio of 86.28, a P/E/G ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analyst Ratings Changes

Several research firms have issued reports on ISRG. Citigroup boosted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Wells Fargo & Company raised their target price on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday, October 18th. Barclays upped their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. Finally, BTIG Research set a $535.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

Institutional Trading of Intuitive Surgical

Several hedge funds and other institutional investors have recently bought and sold shares of ISRG. Massachusetts Financial Services Co. MA acquired a new stake in shares of Intuitive Surgical during the third quarter worth $558,807,000. International Assets Investment Management LLC lifted its holdings in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after acquiring an additional 1,088,415 shares during the period. Capital Research Global Investors acquired a new stake in shares of Intuitive Surgical in the first quarter worth approximately $374,390,000. FMR LLC grew its holdings in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the period. Finally, Vanguard Group Inc. increased its position in Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after purchasing an additional 493,126 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.